Robert Torray - Torray Investment Partners
Holding/activity history for Glaxo Smith Kline (AP47)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2017 Q1 | 0 | 0.00 | Sell 100.00% | 0.03 | SEC | ||
| 2016 Q4 | 6,500 | 0.03 | Reduce 16.13% | <0.01 | $38.46 | $250,000 | SEC |
| 2016 Q3 | 7,750 | 0.04 | $43.10 | $334,000 | SEC | ||
| 2016 Q2 | 7,750 | 0.03 | Buy | 0.03 | $43.35 | $336,000 | SEC |
| 2014 Q4 | 0 | 0.00 | Sell 100.00% | 0.03 | SEC | ||
| 2014 Q3 | 7,750 | 0.03 | $45.94 | $356,000 | SEC | ||
| 2014 Q2 | 7,750 | 0.04 | Buy | 0.04 | $53.42 | $414,000 | SEC |